Received: 14 November 2021
Accepted: 23 February 2022
First Online: 8 March 2022
: Study approval was obtained from the Institutional Review Board of BSMMU (BSMMU/2017/11262). Informed written consent was taken from the adult patients. A complete assurance was given that all information would be kept confidential. The right was being given to the patients not to participate and to discontinue participation at any time in the study with consideration/without penalty. The Declaration of Helsinki’s ethical guidelines were followed in the study.
: Not applicable.
: The authors declare that they have no competing interests.